Abstract:Background: Antihypertensive drug therapies have been reported to be associated with new onset of type 2 diabetes mellitus in some hypertensive patients after prolonged use. Angiotensin converting enzyme (ACE) gene has been found to affect essential hypertension, response of antihypertensive therapies, and glycemic disturbances. Therefore, ACE gene I/D polymorphism may be associated with risk of new onset of type 2 diabetes via metabolic disturbances, glycemic dysregulation, and insulin resistance. Aim: To assess the correlation between ACE gene I/D polymorphism and glycemic disturbance under influence of diuretic and other antihypertensive drug therapies. Materials and methods: We recruited 270 normotensive patients as control (150 men and 120 women), 270 hypertensive patients (95 men and 175 women), and 240 hypertensive with new onset of diabetes patients (80 men and 160 women). All samples were genotyped for ACE gene polymorphic alleles and relationship between different genotypes and anthropometric and clinical parameters along with drug therapies was established and analyzed. Results: Baseline clinical (systolic blood pressure, diastolic blood pressure, and fasting blood glucose level) and anthropometric parameters (height, weight, waist circumference, hip circumference, waist-hip ratio, and body mass index) of study populations were found highly statistically significant ( P < .05) when compared among study groups. Furthermore, genotype wise comparison of all these parameters in essential hypertensive (EH) and essential hypertensive with onset of diabetes (EHNOD) patients found most of them nonsignificant and no variation was found with respect to different genotypes of ACE gene. The genotype wise comparison of clinical parameters among different antihypertensive drug therapy was found statistically nonsignificant in both EH and EHNOD patients. Discussion: Anthropometric parameters can be taken as the risk indicator factors for hypertension and diabetes. However, ACE gene polymorphism may not be a risk factor for development of diabetes in hypertensive patients. Conclusion: The present study suggested that ACE gene polymorphism did not show any significant association with the risk of new onset of diabetes in EH patients and more detailed studies with large population size are needed. [Formula: see text]

ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IN UNTREATED ESSENTIAL HYPERTENSION AND RESPONSE TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

Relationship Between Bradykinin B1 Receptor Gene Polymorphism And Antihypertensive Therapy

Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis]

Insertion/deletion Polymorphism of the Angiotensin I—converting Enzyme Gene in Patients with Hypertension, Non—insulin-Dependent Diabetes Mellitus, and Coronary Heart Disease in Taiwan

Relationship between polymorphisms of renin-angiotensin system gene and pressure-lowering response to irbesartan treatment in hypertension patients

Relationship between polymorphisms in RAS and blood pressure-lowering response to irbesartan in hypertensive patients

Polymorphism of Angiotensin-Converting Enzyme Gene and Type 2 Diabetes

Angiotensin Converting Enzyme Gene Polymorphism Andtype 2 Diabetic Retinopathy

Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population

Association Between Angiotensin Converting Enzyme Gene, Chymase Gene and Regression of Left Ventricular Hypertrophy in Patients Treated with Angiotensin Converting Enzyme Inhibitors

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

A Study on the Relationship of Angiotensin Converting Enzyme Gene QTLs Polymorphism to Cerebrovascular Diseases

Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension

Relationship of Renin‐angiotensin System Polymorphisms with Ambulatory and Central Blood Pressure in Patients with Hypertension

A Sfudy of Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension

Association of Angiotensin Converting Enzyme Gene Polymorphism with Type 2 Diabetes Mellitus

The Polymorphism of Angiotensin I-converting Enzyme Gene in Tumor Tissue of Esophageal Carcinoma Patients

Association Study of Angiotensin Converting Enzyme Polymorphism with Myocardial Infarction in Chinese

Association Between Angiotensin-Converting Enzyme Gene Polymorphism and Diabetic Retinopathy in the Chinese Population

Carotid Remodeling of Hypertensive Subjects and Polymorphism of the Angiotensin-Converting Enzyme Gene.